Kalli Catcott, PhD

Sr. Scientist
Mersana Therapeutics, Massachusetts, United States

Kalli is a Principal Scientist at Mersana Therapeutics working on bioconjugation and antibody drug conjugates. She received her bachelors from UC San Diego and has a PhD from Northeastern University. Kalli has spent the past 15 years making antibody conjugates of all kinds at companies such as ImmunoGen, Amgen, and Mersana. There is a very good chance that she arrived here on a bicycle.

Disclosure information not submitted.

Presentation(s):

• Site-specific Dolasynthen ADCs: A platform to generate a wide range of drug-to-antibody ratios and maintain consistent exposure

  Tuesday, February 8, 2022
  4:30 PM – 5:00 PM